With forthcoming regulatory decisions and innovative formulations on the horizon, now is the time to stay informed and proactive about your treatment choices
Diabetic peripheral neuropathy (DPN) is one of the complications of diabetes mellitus and is caused by neuron injury induced by hyperglycemic circumstances
Limitations of Use Setmelanotide is not indicated for the treatment of patients with the following conditions as setmelanotide would not be expected to be effective: Obesity due to suspected POMC, PCSK1, or LEPR deficiency with POMC, PCSK1, or LEPR variants classified as benign or likely benign Other types of obesity not related to acquired HO, BBS, or POMC, PCSK1 or LEPR deficiency, including obesity associated with other genetic syndromes and general (polygenic) obesity
This helps the body to modulate the immune system, reduce inflammation, and support overall healing
1 Digital simplicity
Extensive research is currently underway on the effects of these drugs with GLP-1RA properties in brain diseases